Potential prognostic factors for predicting the chemotherapeutic outcomes and prognosis of patients with metastatic colorectal cancer

被引:19
|
作者
Zhang, Liqun [1 ]
Zhang, Jingdong [1 ]
Wang, Yuanhe [1 ]
Dong, Qian [1 ]
Piao, Haiyan [1 ]
Wang, Qiwei [1 ]
Zhou, Yang [1 ]
Ding, Yang [1 ]
机构
[1] China Med Univ, Liaoning Canc Hosp & Inst, Med Oncol Dept Gastrointestinal Tumors, Canc Hosp, 44 Xiaohe Rd, Shenyang 110042, Liaoning, Peoples R China
关键词
chemotherapy response; colorectal cancer; FAR; PGR; prealbumin; prealbumin to globulin; LONG-TERM SURVIVAL; GLOBULIN RATIO; NEUTROPHIL-LYMPHOCYTE; INFLAMMATORY STATUS; PLASMA-FIBRINOGEN; ALBUMIN; PHARMACOKINETICS; RESECTION; IMPACT; TUMORS;
D O I
10.1002/jcla.22958
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Objectives The purpose of this study was to explore whether pretreatment potential prognostic factors are related to chemotherapeutic outcomes and the prognosis of inpatients with metastatic colorectal cancer (mCRC) undergoing chemotherapy. Materials and methods Data from 71 patients with mCRC were analyzed retrospectively. The relationship between the potential prognostic factors before first-line chemotherapy and the clinicopathological characteristics and chemotherapy response of the patients was calculated using Fisher's exact test and the chi-square test. The prognostic factors were analyzed using univariate and multivariate analyses. We analyzed the subgroups using the Mann-Whitney U test. Results Four factors were eventually used as prognostic factors, namely the albumin-to-globulin ratio (AGR), the fibrinogen-to-albumin ratio (FAR), the prealbumin-to-globulin ratio (PGR), and the fibrinogen-to-prealbumin ratio (FPR); the cutoff values of the four potential prognostic factors were 1.40, 10.63, 5.44, and 18.49, respectively. The high AGR and PGR groups had a higher response rate than that of the low groups. Patients in the low FAR and FPR groups showed a higher objective response rate than the high FAR and FPR groups. Patients with low FPR were associated with a higher disease control rate than patients with high FPR. Higher progression-free survival (PFS) was observed in the high AGR and PGR and low FAR and FPR groups. The AGR, FAR, PGR, and FPR were considered reliable prognostic factors for PFS in a univariate analysis. Conclusions The prechemotherapy AGR, FAR, PGR, and FPR were good prognostic factors to predict the chemotherapy response and PFS in patients with mCRC.
引用
收藏
页数:13
相关论文
共 50 条
  • [41] The inflammatory prognostic index as a potential predictor of prognosis in metastatic gastric cancer
    Ahmet Ozveren
    Atike Pinar Erdogan
    Ferhat Ekinci
    Scientific Reports, 13
  • [42] Multiple treatment lines and prognosis in metastatic colorectal cancer patients
    Chiara Carlomagno
    Alfonso De Stefano
    Mario Rosanova
    Stefano De Falco
    Laura Attademo
    Giovanni Fiore
    Sabino De Placido
    Cancer and Metastasis Reviews, 2019, 38 : 307 - 313
  • [43] Multiple treatment lines and prognosis in metastatic colorectal cancer patients
    Carlomagno, Chiara
    De Stefano, Alfonso
    Rosanova, Mario
    De Falco, Stefano
    Attademo, Laura
    Fiore, Giovanni
    De Placido, Sabino
    CANCER AND METASTASIS REVIEWS, 2019, 38 (1-2) : 307 - 313
  • [44] Exploration of potential prognostic biomarkers in aflibercept plus FOLFIRI in Japanese patients with metastatic colorectal cancer
    Hamaguchi, Tetsuya
    Denda, Tadamichi
    Kudo, Toshihiro
    Sugimoto, Naotoshi
    Ura, Takashi
    Yamazaki, Kentaro
    Fujii, Hirofumi
    Kajiwara, Takeshi
    Nakajima, Takako Eguchi
    Takahashi, Shin
    Otsu, Satoshi
    Komatsu, Yoshito
    Nagashima, Fumio
    Moriwaki, Toshikazu
    Esaki, Taito
    Sato, Takeo
    Itabashi, Michio
    Oki, Eiji
    Sasaki, Toru
    Chiron, Marielle
    Yoshino, Takayuki
    CANCER SCIENCE, 2019, 110 (11) : 3565 - 3572
  • [45] BRAF and RAS mutations as prognostic factors in metastatic colorectal cancer patients undergoing liver resection
    M Schirripa
    F Bergamo
    C Cremolini
    M Casagrande
    S Lonardi
    G Aprile
    D Yang
    F Marmorino
    G Pasquini
    E Sensi
    C Lupi
    G De Maglio
    N Borrelli
    S Pizzolitto
    G Fasola
    R Bertorelle
    M Rugge
    G Fontanini
    V Zagonel
    F Loupakis
    A Falcone
    British Journal of Cancer, 2015, 112 : 1921 - 1928
  • [46] Predicting Potential Patterns of Metastatic Spread and Outcomes in Breast Cancer
    Purushotham, A.
    Agbaje, O.
    Shamil, E.
    Cariati, M.
    Pinder, S.
    Holmberg, L.
    CANCER RESEARCH, 2010, 70
  • [47] BRAF and RAS mutations as prognostic factors in metastatic colorectal cancer patients undergoing liver resection
    Schirripa, M.
    Bergamo, F.
    Cremolini, C.
    Casagrande, M.
    Lonardi, S.
    Aprile, G.
    Yang, D.
    Marmorino, F.
    Pasquini, G.
    Sensi, E.
    Lupi, C.
    De Maglio, G.
    Borrelli, N.
    Pizzolitto, S.
    Fasola, G.
    Bertorelle, R.
    Rugge, M.
    Fontanini, G.
    Zagonel, V.
    Loupakis, F.
    Falcone, A.
    BRITISH JOURNAL OF CANCER, 2015, 112 (12) : 1921 - 1928
  • [48] Prognostic factors and a survival score for patients with metastatic spinal cord compression from colorectal cancer
    Rades, D.
    Douglas, S.
    Huttenlocher, S.
    Veninga, T.
    Bajrovic, A.
    Rudat, V.
    Schild, S. E.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2012, 188 (12) : 1114 - 1118
  • [49] CYTOKERATINS IN PREDICTING THERAPY RESPONSE AND PROGNOSIS OF COLORECTAL CANCER PATIENTS
    Holdenrieder, S.
    Stieber, P.
    Liska, V.
    Treska, V.
    Topolcan, O.
    Finek, J.
    Holubec, L.
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2011, 49 : S244 - S244
  • [50] Oxidative stress as a biomarker for predicting the prognosis of patients with colorectal cancer
    Sawai, Katsuji
    Goi, Takanori
    Sakamoto, Satoko
    Matsunaka, Takayuki
    Maegawa, Nobuhiro
    Koneri, Kenji
    ONCOLOGY, 2022, 100 (11) : 612 - 619